Hemophilia B Patients in US Face Great Financial, Personal Burden

Hemophilia B Patients in US Face Great Financial, Personal Burden

294447

Hemophilia B Patients in US Face Great Financial, Personal Burden

Severe hemophilia B patients receiving prophylactic, or preventive treatment with factor IX face a significant financial and personal burden, according to data from two U.S. population-based medical databases. These findings were reported in a study, “Clinical, humanistic, and economic burden of severe hemophilia B in the United States: results from the CHESS US and CHESS US+ population surveys,” published in the Orphanet Journal of Rare Diseases. Hemophilia B is an inherited blood disorder caused by…

You must be logged in to read/download the full post.